Plain-English translation of NCT07825857 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called to see if it can help people with methamphetamine use disorder. is already approved by the FDA to treat type 2 diabetes and help with weight management, but researchers want to know if it might also help reduce methamphetamine cravings and use. The trial will compare this medication to a placebo (a harmless salt-water injection) to see which works better.
Right now, there are no FDA-approved medications specifically designed to treat methamphetamine use disorder, even though it affects over 1.5 million Americans every year. Early research suggests this medication might help reduce cravings for stimulants like methamphetamine, so this study will test whether it actually works for this purpose.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will receive either the medication or a placebo as a weekly injection for 26 weeks, plus 6 additional weeks of follow-up visits. You'll come to the clinic once a week to receive your injection and provide urine samples to check for methamphetamine use. Researchers will also ask you questions about your cravings, drug use patterns, and how you're doing overall to see if the treatment is helping you reduce or stop your methamphetamine use.
AI-generated summary from trial data ยท Sep 18, 2026 ยท Not medical advice
United States